INSIDER
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

Robinhood Chain…
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
03 · Corporate insiders

Form 4 filings

Officers, directors and 10% owners must report trades within two business days on SEC Form 4. INSIDER parses each filing's XML from EDGAR. By default only discretionary open-market purchases and sales are shown; grants, option exercises and tax withholding are one click away.

Form 4 transactions

Cluster activity · 60d

Most active filers

Companies with the most Form 4 filings
Data sources
SEC Form 43h ago
House PTR3h ago
SEC 13F3h ago
Robinhood Chain3h ago

Most active filers · 30d

  1. 01Kurtz George0B / 204S204 trades$51.20M
  2. 02SPSaba Capital Management, L.P.68B / 23S · 14 late91 trades$30.01M
  3. 03ATAdair Kathleen Theresa52B / 0S · 52 late52 trades$18K
  4. 04AJAllaire Jeremy0B / 50S50 trades$4.26M
  5. 05Wilhelmsen Arne Alexander0B / 47S47 trades$241.96M
  6. 06SJSheena Jonathan0B / 43S43 trades$3.14M
  7. 07CFCheng Chi Fung0B / 42S42 trades$15.33M
  8. 08SLSpeiser Michael L0B / 35S35 trades$14.00M
  9. 09RARothblatt Martine A0B / 33S33 trades$5.50M
  10. 10RJRubinstein Julie0B / 33S33 trades$5.33M

Cluster activity · 60d

  1. BUYTSMTAIWAN SEMICONDUCTOR MANUFACTURING CO LTDNov 5 – Nov 631 insiders$417K
  2. SELLDRDDRDGOLD LTDOct 27 – Oct 2710 insiders$1.23M
  3. BUYMTDRMatador Resources CoNov 5 – Nov 99 insiders$642K
  4. SELLFERGFerguson Enterprises Inc. /DE/Oct 12 – Oct 167 insiders$7.38M
  5. SELLSYMSymbotic Inc.Oct 26 – Nov 27 insiders$1.98M
  6. BUYUPBDUPBOUND GROUP, INC.Nov 2 – Nov 37 insiders$1.34M
  7. SELLADUSAddus HomeCare CorpNov 6 – Nov 96 insiders$16.28M
  8. SELLARQQArqit Quantum Inc.Oct 2 – Oct 136 insiders$369K

Form 4 transactions

67,560 records
Side
allbuysell
Score
any≥ 30≥ 50≥ 70
Sort
Newest disclosedNewest executedInsider ScoreValue
Include
grants & admin
ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
7
GP
Gallup PatriciaDirector, Chairman & Chief Admin Officer, 10% Owner
CNXNPC CONNECTION INC
Open-market sale · 10b5-1 plan
SELL$307K
3,922 sh
Aug 18, 2026
Page 484 of 1689
← PrevNext →
Aug 19, 2026
traded Aug 18, 2026
+1d
SEC Form 4

Evidence

7
EM
Ellenbogen MichaelDirector
EVLVEvolv Technologies Holdings, Inc.
Open-market sale · 10b5-1 plan
SELL$451K
80.8K sh
Aug 17, 2026Aug 19, 2026
traded Aug 17, 2026
+2dSEC Form 4

Evidence

7
GP
Gallup PatriciaDirector, Chairman & Chief Admin Officer, 10% Owner
CNXNPC CONNECTION INC
Open-market sale · 10b5-1 plan
SELL$254K
3,220 sh
Aug 18, 2026Aug 19, 2026
traded Aug 18, 2026
+1dSEC Form 4

Evidence

7
BM
Brosius MarkEVP & Chief Mfg and Supply Cha
ISRGINTUITIVE SURGICAL INC
Open-market sale · 10b5-1 plan
SELL$30K
77 sh
Aug 18, 2026Aug 19, 2026
traded Aug 18, 2026
+1dSEC Form 4

Evidence

7
BM
Brosius MarkEVP & Chief Mfg and Supply Cha
ISRGINTUITIVE SURGICAL INC
Open-market sale · 10b5-1 plan
SELL$30K
77 sh
Aug 19, 2026Aug 19, 2026
traded Aug 19, 2026
+0dSEC Form 4

Evidence

6
GV
Gupta VikramSee Remarks
SYNASYNAPTICS Inc
Open-market sale · 10b5-1 plan
SELL$121K
1,167 sh
Aug 18, 2026Aug 19, 2026
traded Aug 18, 2026
+1dSEC Form 4

Evidence

6
FM
Fruhbeis Todd MichaelDirector
STRRStar Equity Holdings, Inc.
Option exercise
M—
535 sh
Aug 18, 2026Aug 19, 2026
traded Aug 18, 2026
+1dSEC Form 4

Evidence

6
GV
Gupta VikramSee Remarks
SYNASYNAPTICS Inc
Open-market sale · 10b5-1 plan
SELL$168K
1,633 sh
Aug 18, 2026Aug 19, 2026
traded Aug 18, 2026
+1dSEC Form 4

Evidence

6
SS
Schwartz SophiaChief Legal Officer, Secretary
NXDRNextdoor Holdings, Inc.
Open-market sale · 10b5-1 plan
SELL$6,286
2,500 sh
Aug 17, 2026Aug 19, 2026
traded Aug 17, 2026
+2dSEC Form 4

Evidence

6
GV
Gupta VikramSee Remarks
SYNASYNAPTICS Inc
Open-market sale · 10b5-1 plan
SELL$155K
1,477 sh
Aug 18, 2026Aug 19, 2026
traded Aug 18, 2026
+1dSEC Form 4

Evidence

5
GC
Gentleman CourtneySee remarks
SYFSynchrony Financial
Grant or award
A$6,379
79 sh
Aug 17, 2026Aug 19, 2026
traded Aug 17, 2026
+2dSEC Form 4

Evidence

5
GS
Griffis SarahChief Technology Officer
MAPSWM TECHNOLOGY, INC.
Tax withholding
F$24K
59.0K sh
Aug 17, 2026Aug 19, 2026
traded Aug 17, 2026
+2dSEC Form 4

Evidence

5
KA
Kreitzer AnatolChief Discovery Officer
MPLTMapLight Therapeutics, Inc.
Grant or award
A—
24.5K sh
Aug 17, 2026Aug 19, 2026
traded Aug 17, 2026
+2dSEC Form 4

Evidence

5
CL
Campbell Renee LSVP, Capital Markets & Risk
VMIVALMONT INDUSTRIES INC
Option exercise
M—
838 sh
Aug 17, 2026Aug 19, 2026
traded Aug 17, 2026
+2dSEC Form 4

Evidence

5
HR
Hamady Robert RamseyChief Financial Officer
SMRNUSCALE POWER Corp
Open-market sale · 10b5-1 plan
SELL$0
0 sh
Aug 17, 2026Aug 19, 2026
traded Aug 17, 2026
+2dSEC Form 4

Evidence

5
CM
Cieri MichaelChief Product Officer
BILLBILL Holdings, Inc.
Grant or award
A—
19.6K sh
Aug 17, 2026Aug 19, 2026
traded Aug 17, 2026
+2dSEC Form 4

Evidence

5
PJ
Palmer JenniferDirector
STRRStar Equity Holdings, Inc.
Option exercise
M—
460 sh
Aug 18, 2026Aug 19, 2026
traded Aug 18, 2026
+1dSEC Form 4

Evidence

5
BR
Britt Christopher RDirector, Chief Executive Officer
CHYMChime Financial, Inc.
Gift
G—
11.4K sh
Aug 18, 2026Aug 19, 2026
traded Aug 18, 2026
+1dSEC Form 4

Evidence

5
PA
Parks Louis A.Director
STRRStar Equity Holdings, Inc.
Option exercise
M—
485 sh
Aug 18, 2026Aug 19, 2026
traded Aug 18, 2026
+1dSEC Form 4

Evidence

5
KA
Kreitzer AnatolChief Discovery Officer
MPLTMapLight Therapeutics, Inc.
Grant or award
A—
6,020 sh
Aug 17, 2026Aug 19, 2026
traded Aug 17, 2026
+2dSEC Form 4

Evidence

5
OD
Owens DarrellSee remarks
SYFSynchrony Financial
Grant or award
A$5,653
70 sh
Aug 17, 2026Aug 19, 2026
traded Aug 17, 2026
+2dSEC Form 4

Evidence

5
Field DylanDirector, President & CEO, 10% Owner
FIGFigma, Inc.
Gift
G—
1.25M sh
Aug 17, 2026Aug 19, 2026
traded Aug 17, 2026
+2dSEC Form 4

Evidence

5
GV
Gupta VikramSee Remarks
SYNASYNAPTICS Inc
Tax withholding · 10b5-1 plan
F$1.96M
17.7K sh
Aug 17, 2026Aug 19, 2026
traded Aug 17, 2026
+2dSEC Form 4

Evidence

5
HC
Howse CurtisSee remarks
SYFSynchrony Financial
Grant or award
A$15K
182 sh
Aug 17, 2026Aug 19, 2026
traded Aug 17, 2026
+2dSEC Form 4

Evidence

5
HJ
Howe JolandaSVP, GLOBAL CONTROLLER
MIRMMirum Pharmaceuticals, Inc.
Option exercise
M—
40.0K sh
Aug 18, 2026Aug 19, 2026
traded Aug 18, 2026
+1dSEC Form 4

Evidence

4
WJ
Wetterwald JulienChief Technology Officer
WLTHWEALTHFRONT CORP
Open-market sale · 10b5-1 plan
SELL$140K
15.3K sh
Aug 17, 2026Aug 19, 2026
traded Aug 17, 2026
+2dSEC Form 4

Evidence

4
HB
Hohl BenjaminCHIEF FINANCIAL OFFICER
ELVNEnliven Therapeutics, Inc.
Open-market sale · 10b5-1 plan
SELL$82K
1,388 sh
Aug 17, 2026Aug 19, 2026
traded Aug 17, 2026
+2dSEC Form 4

Evidence

3
SE
Song EstherSee Remarks
SYNASYNAPTICS Inc
Open-market sale · 10b5-1 plan
SELL$9,941
96 sh
Aug 18, 2026Aug 19, 2026
traded Aug 18, 2026
+1dSEC Form 4

Evidence

3
SE
Song EstherSee Remarks
SYNASYNAPTICS Inc
Open-market sale · 10b5-1 plan
SELL$17K
164 sh
Aug 18, 2026Aug 19, 2026
traded Aug 18, 2026
+1dSEC Form 4

Evidence

3
SE
Song EstherSee Remarks
SYNASYNAPTICS Inc
Open-market sale · 10b5-1 plan
SELL$18K
177 sh
Aug 18, 2026Aug 19, 2026
traded Aug 18, 2026
+1dSEC Form 4

Evidence

2
FP
Foff Erin PennockChief Medical Officer
MPLTMapLight Therapeutics, Inc.
Grant or award
A—
54.2K sh
Aug 17, 2026Aug 19, 2026
traded Aug 17, 2026
+2dSEC Form 4

Evidence

2
FP
Foff Erin PennockChief Medical Officer
MPLTMapLight Therapeutics, Inc.
Grant or award
A—
13.4K sh
Aug 17, 2026Aug 19, 2026
traded Aug 17, 2026
+2dSEC Form 4

Evidence

2
FM
Fruhbeis Todd MichaelDirector
STRRStar Equity Holdings, Inc.
Option exercise
M—
535 sh
Aug 18, 2026Aug 19, 2026
traded Aug 18, 2026
+1dSEC Form 4

Evidence

1
KS
Kereere SuzanPresident, Global Markets
PYPLPayPal Holdings, Inc.
Open-market sale · 10b5-1 plan
SELL$49K
800 sh
Aug 18, 2026Aug 19, 2026
traded Aug 18, 2026
+1dSEC Form 4

Evidence

1
DA
Dasdan AliChief Technology Officer
DBXDROPBOX, INC.
Tax withholding · 10b5-1 plan
F$663K
19.3K sh
Aug 17, 2026Aug 19, 2026
traded Aug 17, 2026
+2dSEC Form 4

Evidence

1
SM
Starzak Alissa MichelleChief Legal Officer
NETCloudflare, Inc.
Option exercise · 10b5-1 plan
M$259K
3,333 sh
Aug 17, 2026Aug 19, 2026
traded Aug 17, 2026
+2dSEC Form 4

Evidence

1
HJ
Herrington Douglas JCEO Worldwide Amazon Stores
AMZNAMAZON COM INC
Option exercise · 10b5-1 plan
M—
9,352 sh
Aug 15, 2026Aug 19, 2026
traded Aug 15, 2026
+4dSEC Form 4

Evidence

0
LX
Lin XichenCHIEF SCIENTIFIC OFFICER
GPCRStructure Therapeutics Inc.
Derivative conversion · 10b5-1 plan
C—
11.8K sh
Aug 18, 2026Aug 19, 2026
traded Aug 18, 2026
+1dSEC Form 4

Evidence

0
RJ
Riley JanelChief Accounting Officer
NETCloudflare, Inc.
Option exercise · 10b5-1 plan
M$113K
1,667 sh
Aug 17, 2026Aug 19, 2026
traded Aug 17, 2026
+2dSEC Form 4

Evidence

0
LX
Lin XichenCHIEF SCIENTIFIC OFFICER
GPCRStructure Therapeutics Inc.
Option exercise · 10b5-1 plan
M—
11.8K sh
Aug 18, 2026Aug 19, 2026
traded Aug 18, 2026
+1dSEC Form 4

Evidence